VolitionRX Investor Relations Material
Latest events
Q3 2024
VolitionRX
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from VolitionRX Ltd
Access all reports
VolitionRX Ltd is a multi-national epigenetics company that specializes in the development of blood tests through its proprietary Nucleosomics™ platform. This platform is designed to create simple, easy-to-use, and cost-effective blood tests aimed at diagnosing and monitoring a variety of life-altering diseases, including some cancers and diseases related to NETosis, such as sepsis and COVID-19. The company is headquartered in Henderson, Nevada, and its shares are listed on the NYSE American under the ticker symbol VNRX.
Key slides for VolitionRX Ltd
Status Update
VolitionRX Ltd
Status Update
VolitionRX Ltd
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
VNRX
Country
🇺🇸 United States